CAR T cell manufacturing: where are we heading?
Weiguo Dai, Ph.D. (Janssen R&D)
Cell therapy with genetically engineered cells to express either chimeric antigen receptors (CAR) or T-cell receptors has emerged as a novel cancer treatment. Two autologous CAR T cell products (Kymriah™ and Yescarta™) were recently approved by FDA. For cell therapy, the cell manufacturing is a critical step and remains a great challenge. In this presentation, the speaker will review the current CAR T cell manufacturing process, discuss the major challenges, and share the insights in the opportunities to develop the next generation of cell drug product manufacturing process.
Date and Location
Thurs Oct 18th, 2018Registration & social hour: 5:30 PM |
Meeting SponsorsTBD |
Hanover Marriott1401 Rt 10 East,Whippany, NJ 07981 |
About the speaker
Dr. Weiguo Dai is a Scientific Director in Large Molecule Drug Product Development in Janssen Research & Development. Dr. Dai’s scientific and industrial impact has been reflected by his election into the Inaugural Janssen Fellow Community (globally total of 62), and the Fellow of American Association of Pharmaceutical Scientists (AAPS) in 2013. Dr. Dai is also the recipient of several scientific awards including Johnson and Johnson 2011 Philip B. Hofmann Research Scientist Award.
Dr. Dai’s research and innovation have focused on biologics (antibodies, proteins, peptides, DNA and cells) drug product development including formulation and process development, drug delivery technologies/devices, scale-up, tech transfer, and manufacturing. Dr. Dai’s work has resulted in over 50 peer-reviewed journal research articles.
Dr. Dai has been a passionate volunteer in building a collaborative pharmaceutical community. He is currently serving as AAPS National Fellow Election Committee Member and served as Chair of AAPS Physical Pharmacy and Biopharmaceutics Section (2014-2015). Additionally, Dr. Dai served as Headquarter President (2015-2016) and Greater-Philadelphia Area Chapter President (2013-2014) of Sino-American Pharmaceutical Professionals Association (SAPA), a professional organization with 7 regional chapters and over 6,000 members globally.
Dr. Dai earned his PhD degree from The Johns Hopkins University, and has over 20 years of US industrial work experience in biotech/pharmaceutical companies, including Amgen, and Johnson and Johnson.
Registration Fees
-
Registered and paid online: $50.00
-
Walk-in: $65.00
-
Between-positions, Retirees & Students (WITH ADVANCE REGISTRATION ONLY): $45.00
Advance registration will end at 5:00 PM on WEDNESDAY OCT 17th; after that, you must pay at the door. Note also that if you choose the "Register Now and Pay at Meeting" option, you must proceed all the way to the "Your Order is Confirmed" screen or your registration will not be recorded.
Note: in the event a meeting needs to be cancelled due to weather or other conditions, NJPhAST will do its best to notify all registrants as soon as possible; however, we ask that you exercise individual judgement if you do not hear directly from NJPhAST.